Vanguard Personalized Indexing Management LLC Grows Position in McKesson Corporation $MCK

Vanguard Personalized Indexing Management LLC boosted its stake in McKesson Corporation (NYSE:MCK) by 5.3% in the 4th quarter, Holdings Channel reports. The firm owned 23,327 shares of the company’s stock after purchasing an additional 1,169 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in McKesson were worth $19,135,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in MCK. Venture Visionary Partners LLC lifted its stake in McKesson by 9.7% during the 4th quarter. Venture Visionary Partners LLC now owns 1,014 shares of the company’s stock worth $832,000 after acquiring an additional 90 shares in the last quarter. Panagora Asset Management Inc. lifted its stake in McKesson by 15.7% during the 4th quarter. Panagora Asset Management Inc. now owns 299,595 shares of the company’s stock worth $245,755,000 after acquiring an additional 40,654 shares in the last quarter. Public Employees Retirement Association of Colorado lifted its stake in McKesson by 74.9% during the 4th quarter. Public Employees Retirement Association of Colorado now owns 269,282 shares of the company’s stock worth $220,889,000 after acquiring an additional 115,311 shares in the last quarter. Sands Capital Management LLC lifted its stake in McKesson by 10.9% during the 4th quarter. Sands Capital Management LLC now owns 174,268 shares of the company’s stock worth $142,950,000 after acquiring an additional 17,122 shares in the last quarter. Finally, SHUTTLEWORTH & Co lifted its position in shares of McKesson by 1.1% during the fourth quarter. SHUTTLEWORTH & Co now owns 3,007 shares of the company’s stock worth $2,467,000 after purchasing an additional 34 shares in the last quarter. Institutional investors and hedge funds own 85.07% of the company’s stock.

McKesson Stock Down 0.0%

NYSE:MCK opened at $783.88 on Monday. The company has a fifty day simple moving average of $798.10 and a two-hundred day simple moving average of $846.19. The company has a market cap of $94.22 billion, a price-to-earnings ratio of 20.38, a price-to-earnings-growth ratio of 1.29 and a beta of 0.31. McKesson Corporation has a 52 week low of $637.00 and a 52 week high of $999.00.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Thursday, May 7th. The company reported $11.69 EPS for the quarter, topping the consensus estimate of $11.56 by $0.13. The business had revenue of $96.30 billion during the quarter, compared to the consensus estimate of $101.35 billion. McKesson had a net margin of 1.18% and a negative return on equity of 345.35%. The company’s quarterly revenue was up 6.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $10.12 earnings per share. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. On average, analysts expect that McKesson Corporation will post 44.28 EPS for the current year.

McKesson Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 1st. Shareholders of record on Monday, June 1st will be paid a $0.82 dividend. The ex-dividend date is Monday, June 1st. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s payout ratio is 8.53%.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Barclays reduced their price target on shares of McKesson from $1,050.00 to $925.00 and set an “overweight” rating on the stock in a research report on Wednesday, June 10th. Bank of America reduced their price target on shares of McKesson from $1,040.00 to $1,000.00 and set a “buy” rating on the stock in a research report on Monday, April 6th. Wall Street Zen raised shares of McKesson from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Wells Fargo & Company reduced their price target on shares of McKesson from $925.00 to $812.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 12th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $875.00 price target on shares of McKesson in a research note on Friday, May 8th. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $960.53.

Insider Buying and Selling at McKesson

In other McKesson news, EVP Thomas L. Rodgers sold 2,388 shares of the business’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $761.09, for a total value of $1,817,482.92. Following the completion of the transaction, the executive vice president owned 3,090 shares in the company, valued at $2,351,768.10. The trade was a 43.59% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Michele Lau sold 3,550 shares of the business’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $761.09, for a total transaction of $2,701,869.50. Following the transaction, the executive vice president owned 3,247 shares of the company’s stock, valued at approximately $2,471,259.23. The trade was a 52.23% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 11,822 shares of company stock worth $8,986,212. 0.08% of the stock is currently owned by insiders.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.